1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Psoriatic Arthritis Treatment Market
2.2. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2023 (US$ Million)
2.3. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2023 (US$ Million)
2.4. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2023 (US$ Million)
2.5. Global Psoriatic Arthritis Treatment Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Psoriatic Arthritis Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Psoriatic Arthritis Treatment Market Vendors
3.2. Strategies Adopted by Psoriatic Arthritis Treatment Market Vendors
3.3. Key Industry Strategies
4. Psoriatic Arthritis Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Psoriatic Arthritis Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. TNF Inhibitors
5.3.2. Interleukin Inhibitors
5.3.3. PDE4 Inhibitors
5.3.4. Others

6. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oral
6.3.2. Parenteral
6.3.3. Topical

7. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies


8. North America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

9. UK and European Union Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.4.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.4.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.5.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.5.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.5.1.6.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.5.1.6.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

10. Asia Pacific Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.4.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.4.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.5.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.5.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.5.1.6.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.5.1.6.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

11. Latin America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

12. Middle East and Africa Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

13. Company Profile
13.1. Pfizer
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Johnson & Johnson
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. AbbVie
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Janssen Pharmaceutical NV
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Novartis AG
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. mgen, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Celgene Corporation
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Eli Lilly and Company
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Bristol Myers Squibb
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. UCB S.A.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Other Notable Players
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives